PMID- 37740834 OWN - NLM STAT- MEDLINE DCOM- 20240124 LR - 20240315 IS - 1559-0100 (Electronic) IS - 1355-008X (Print) IS - 1355-008X (Linking) VI - 83 IP - 1 DP - 2024 Jan TI - Sleep disorders during pregnancy: an underestimated risk factor for gestational diabetes mellitus. PG - 41-50 LID - 10.1007/s12020-023-03537-x [doi] AB - Sleep disorders are highly prevalent during pregnancy and significantly affect women's health and quality of life. Gestational diabetes mellitus (GDM) is one of the most common metabolic complications during pregnancy and constitutes a significant risk factor for both mother and fetus in the short and the long term. While the association between sleep disorders and type 2 diabetes mellitus (T2DM) is indisputable, it is not clear whether there is a link between sleep disorders and GDM. The aim of this article was to investigate the association between sleep disorders and GDM and whether the treatment of sleep disorders may prevent GDM development. Insomnia, obstructive sleep apnea (OSA), restless legs syndrome (RLS), and narcolepsy were the most common sleep disorders identified during pregnancy and were related to poor sleep quality and short or prolonged sleep duration. They were all associated with an increased risk of GDM. The ideal sleep duration for pregnant women was determined at 8-9 h daily. In conclusion, sleep disorders constitute a risk factor for GDM. It is imperative that prospective studies be conducted to evaluate the effect of the early management of sleep disorders on GDM manifestation and control. Healthcare providers should highlight the importance of sufficient sleep to reinforce pregnancy outcomes. CI - (c) 2023. The Author(s). FAU - Eleftheriou, Danai AU - Eleftheriou D AD - Respiratory Medicine Unit, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. FAU - Athanasiadou, Kleoniki I AU - Athanasiadou KI AUID- ORCID: 0000-0002-0811-8156 AD - Endocrine Unit and Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. FAU - Sifnaios, Emmanouil AU - Sifnaios E AD - Allergy & Clinical Immunology, Private Clinic, Kalamata, Greece. FAU - Vagiakis, Emmanouil AU - Vagiakis E AD - Respiratory Department, First ICU Evangelismos Hospital Athens, National and Kapodistrian University of Athens, Athens, Greece. FAU - Katsaounou, Paraskevi AU - Katsaounou P AD - Respiratory Department, First ICU Evangelismos Hospital Athens, National and Kapodistrian University of Athens, Athens, Greece. FAU - Psaltopoulou, Theodora AU - Psaltopoulou T AUID- ORCID: 0000-0002-1404-9716 AD - Endocrine Unit and Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. FAU - Paschou, Stavroula A AU - Paschou SA AUID- ORCID: 0000-0002-0651-1376 AD - Endocrine Unit and Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. s.a.paschou@gmail.com. FAU - Trakada, Georgia AU - Trakada G AD - Respiratory Medicine Unit, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. LA - eng PT - Journal Article PT - Review DEP - 20230923 PL - United States TA - Endocrine JT - Endocrine JID - 9434444 SB - IM MH - Pregnancy MH - Female MH - Humans MH - *Diabetes, Gestational/epidemiology/etiology MH - Prospective Studies MH - *Diabetes Mellitus, Type 2/complications/epidemiology MH - Quality of Life MH - Pregnancy Outcome MH - Risk Factors MH - *Sleep Wake Disorders/complications/epidemiology PMC - PMC10805805 OTO - NOTNLM OT - GDM OT - Gestational diabetes mellitus OT - Insomnia OT - Narcolepsy OT - Obstructive sleep apnea OT - RLS COIS- The authors declare no competing interests. EDAT- 2023/09/23 20:42 MHDA- 2024/01/24 06:43 PMCR- 2023/09/23 CRDT- 2023/09/23 11:08 PHST- 2023/04/30 00:00 [received] PHST- 2023/09/12 00:00 [accepted] PHST- 2024/01/24 06:43 [medline] PHST- 2023/09/23 20:42 [pubmed] PHST- 2023/09/23 11:08 [entrez] PHST- 2023/09/23 00:00 [pmc-release] AID - 10.1007/s12020-023-03537-x [pii] AID - 3537 [pii] AID - 10.1007/s12020-023-03537-x [doi] PST - ppublish SO - Endocrine. 2024 Jan;83(1):41-50. doi: 10.1007/s12020-023-03537-x. Epub 2023 Sep 23.